<?xml version="1.0" encoding="UTF-8"?>
<ref id="B124-materials-13-04532">
 <label>124.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Coplan</surname>
    <given-names>P.M.</given-names>
   </name>
   <name>
    <surname>Noel</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Levitan</surname>
    <given-names>B.S.</given-names>
   </name>
   <name>
    <surname>Ferguson</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Mussen</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>Development of a Framework for Enhancing the Transparency, Reproducibility and Communication of the Benefit-Risk Balance of Medicines</article-title>
  <source>Clin. Pharmacol. Ther.</source>
  <year>2011</year>
  <volume>89</volume>
  <fpage>312</fpage>
  <lpage>315</lpage>
  <pub-id pub-id-type="doi">10.1038/clpt.2010.291</pub-id>
  <pub-id pub-id-type="pmid">21160469</pub-id>
 </element-citation>
</ref>
